According to Gilead Sciences's latest financial reports the company's current earnings (TTM) are $5.81 B. In 2021 the company made an earning of $8.27 B an increase over its 2020 earnings that were of $1.66 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 (TTM) | $5.81 B | -29.77% |
2021 | $8.27 B | 395.99% |
2020 | $1.66 B | -67.66% |
2019 | $5.16 B | -33.84% |
2018 | $7.79 B | -42.35% |
2017 | $13.52 B | -20.87% |
2016 | $17.09 B | -21.06% |
2015 | $21.65 B | 45.79% |
2014 | $14.85 B | 253.02% |
2013 | $4.20 B | 16.51% |
2012 | $3.61 B | -1.07% |
2011 | $3.65 B | -6.71% |
2010 | $3.91 B | 11.75% |
2009 | $3.50 B | 28.07% |
2008 | $2.73 B | 20.44% |
2007 | $2.27 B | -455.74% |
2006 | -$0.64 B | -154.93% |
2005 | $1.16 B | 76.99% |
2004 | $0.65 B | -266.16% |
2003 | -$0.4 B | -638.24% |
2002 | $73.39 M | 31.5% |
2001 | $55.81 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $22.00 B | 278.41% | ๐บ๐ธ USA |
![]() Pfizer PFE | $35.96 B | 518.64% | ๐บ๐ธ USA |
![]() AbbVie ABBV | $13.47 B | 131.80% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $6.80 B | 17.07% | ๐บ๐ธ USA |
![]() Amgen AMGN | $7.34 B | 26.35% | ๐บ๐ธ USA |
![]() Biogen BIIB | $3.59 B | -38.22% | ๐บ๐ธ USA |
![]() Illumina ILMN | -$4.31 B | -174.13% | ๐บ๐ธ USA |
![]() Vertex Pharmaceuticals VRTX | $4.28 B | -26.26% | ๐บ๐ธ USA |
![]() Merck MRK | $17.40 B | 199.38% | ๐บ๐ธ USA |